Skip to main content Skip to page footer

Clinical trials

As a clinical partner of NCT Heidelberg, you can explore clinical trials for your patients and find information on eligibility criteria and referral procedures.  If you have questions about a specific clinical trial, please do not hesitate to contact us directly using the contact details provided.

Information about clinical trials for patients is available in the “For Patients" section.

Are you looking for a suitable trial for your patients?

Please contact our Clinical Trial Hotline for medical colleagues:

06221 / 56-32884

We are available Monday through Thursday from 9 a.m. to 4 p.m. and on Fridays from 9 a.m. to 2 p.m.

Patients or family members should direct their inquiries to the contacts listed.

Would you like to search for clinical trials directly ?

Clinical Trials at NCT Heidelberg

Clinical trials by cancer type or disease area:

Search for Clinical Trials at NCT Heidelberg and Beyond

Directories of oncology clinical trials with search function

The ONCOnnect platform provides on the website CCC-trials.de an overview of current clinical trials conducted at Comprehensive Cancer Centers across Germany. 

The QuickQueck platform provides information on clinical trials at NCT Heidelberg, as well as oncology trials recruiting patients in Germany and other German-speaking countries.

Explore oncology clinical  trials conducted at our partner institution, Mannheim Comprehensive Cancer Center at Heidelberg University Hospital – UK Mannheim GmbH.

 

The NCT Study Finder provides patients with clear, easy-to-understand information about clinical trials funded by the National Center for Tumor Diseases (NCT) and conducted at one or more of the six NCT sites across Germany.

 

Clinical Trials Newsletter

Our clinical trials newsletter provides quarterly updates highlighting  selected clinical trials. You can subscribe to the newsletter here. Your personal data will be processed in accordance with the General Data Protection Regulation, and you can unsubscribe at any time

Please note: the newsletter is available in German